Thrombosis & Haemostasis society of Australia and New Zealand

Promote Excellence in clinical care for people with clotting and bleeding disorders.

Our Story

Education & Training

Lead education and training for scientists and clinicians in the field

Find Training

Clinical Research

Foster innovation through research, discovery and clinical trials

View Research

Policy & Advocacy

Advocate and develop policies that improve health outcomes

View Resources

About THANZ

Our story

The THANZ was founded following discussions amongst coagulation enthusiasts led by Beng Chong, who had met together for the 1993 annual HSA meeting in Hobart. Until that time, clotters had consoled themselves within a loose association or "club" and the membership of this club was automatically inherited by THANZ...

MEMBER-OnLY Events

Network and learn form clinicians and researchers who are pioneering the industry

Member-only Resources

Access information and resources via our members-only web portal

Regular Newsletters

Stay up to date with regular news updates delivered directly to your inbox

Access to a community

Access to a highly active and qualified community of professional

Find out more

Upcoming Events & Workshops

THANZ Scientific Workshop 2024

October 26, 2024
8:00 am - 5:00 pm

The THANZ Scientific Workshop is for THANZ and non-THANZ members alike; clinicians, scientists and researchers working in the fields of thrombosis and haemophilia. These interactive coagulation workshops are held under the banner of THANZ each year on the eve of the Blood meeting. Previous workshops have been held in New Zealand and all six Australian […]

View details

Latest news

2024 S&E Travel Grants Awarded

July 30th, 2024

This year THANZ awarded 6 S&E Travel Grants to the following members, who travelled to ISTH, Bangkok Rowena Brook, Emma Leitinger, Mitchell Moon, Caitlin Rice, Mark Schreuder and Trish Wise ...

2024 S&E Research Grants Awarded

July 30th, 2024

This year THANZ awarded S&E Research Grants to the following members mma Leitinger (Monash Health, Vic)Comparability of anti-Xa assessments using alternate calibration curves in patients...

IVIg use for Heparin induced thrombocytopenia (HIT) and Vaccine induced thrombotic thrombocytopenia (VITT)

February 29th, 2024

The National Blood Authority (NBA) has approved the inclusion of 5 indications of Heparin induced thrombocytopenia (HIT) in the Criteria for the clinical use of immunoglobulin in Australia (the C...

National COVID-19 Clinical Evidence Taskforce Guidelines

December 20th, 2023

The COVID-19 Vaccine Claims Scheme is being extended The COVID-19 Vaccine Claims Scheme is due to close on 17 April 2024. However, following the Mid-Year Economic and Fiscal Outlook (MYEFO) update pub...

ARES Study published

November 1st, 2023

The THANZ Anticoagulation Reversal and Events Study (ARES) Collaborative has recently published the results of the ARES Study. The paper is available here

2023 S&E Research Grants Awarded

July 11th, 2023

This year THANZ awarded S&E Research Grants to the following members Gabriella Pennings (ANZAC Research Institute/Sydney Local Health District)Mechanism/s of acute IL-1β release fro...

View all